BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Meddens CA, van der List ACJ, Nieuwenhuis EES, Mokry M. Non-coding DNA in IBD: from sequence variation in DNA regulatory elements to novel therapeutic potential. Gut 2019;68:928-41. [PMID: 30692146 DOI: 10.1136/gutjnl-2018-317516] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Yang J, Chen J, Ji Q, Li K, Deng C, Kong X, Xie S, Zhan W, Mao Z, Zhang B, Yu Y, Li D, Cao Y, Ye K, Liu Q, Wu M, Chen F, Chen P. Could routine forensic STR genotyping data leak personal phenotypic information? Forensic Sci Int 2022;335:111311. [PMID: 35468577 DOI: 10.1016/j.forsciint.2022.111311] [Reference Citation Analysis]
2 Kwak MS, Cha JM, Jeon JW, Yoon JY, Park SB. Uncovering Novel Pre-Treatment Molecular Biomarkers for Anti-TNF Therapeutic Response in Patients with Crohn’s Disease. JFB 2022;13:36. [DOI: 10.3390/jfb13020036] [Reference Citation Analysis]
3 Thymiakou E, Xenikaki E, Kardassis D. Intestine-specific ablation of the Hepatocyte Nuclear Factor 4a (Hnf4a) gene in mice has minimal impact on serum lipids and ileum gene expression profile due to upregulation of its paralog Hnf4g. Biochim Biophys Acta Mol Cell Biol Lipids 2021;1867:159108. [PMID: 34973414 DOI: 10.1016/j.bbalip.2021.159108] [Reference Citation Analysis]
4 Lange M, Begolli R, Giakountis A. Non-Coding Variants in Cancer: Mechanistic Insights and Clinical Potential for Personalized Medicine. Noncoding RNA 2021;7:47. [PMID: 34449663 DOI: 10.3390/ncrna7030047] [Reference Citation Analysis]
5 Si W, Huang Z, Li X, Zhao L, Ji Y, Li H, Liu X, Ye S, Chen D, Liu H, Kuang W, Zhu M. Super-enhancer-driven Sorting Nexin 5 expression promotes dopaminergic neuronal ferroptosis in Parkinson's disease models. Biochem Biophys Res Commun 2021;567:35-41. [PMID: 34134000 DOI: 10.1016/j.bbrc.2021.06.024] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Wang Z, Guo K, Gao P, Pu Q, Lin P, Qin S, Xie N, Hur J, Li C, Huang C, Wu M. Microbial and genetic-based framework identifies drug targets in inflammatory bowel disease. Theranostics 2021;11:7491-506. [PMID: 34158863 DOI: 10.7150/thno.59196] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
7 van Deuren RC, Arts P, Cavalli G, Jaeger M, Steehouwer M, van de Vorst M, Gilissen C, Joosten LAB, Dinarello CA, Mhlanga MM, Kumar V, Netea MG, van de Veerdonk FL, Hoischen A. Impact of rare and common genetic variation in the interleukin-1 pathway on human cytokine responses. Genome Med 2021;13:94. [PMID: 34034819 DOI: 10.1186/s13073-021-00907-w] [Reference Citation Analysis]
8 Verma P, Srivastava A, Srikanth CV, Bajaj A. Nanoparticle-mediated gene therapy strategies for mitigating inflammatory bowel disease. Biomater Sci 2021;9:1481-502. [PMID: 33404019 DOI: 10.1039/d0bm01359e] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Cruz MAD, Lund D, Szekeres F, Karlsson S, Faresjö M, Larsson D. Cis-regulatory elements in conserved non-coding sequences of nuclear receptor genes indicate for crosstalk between endocrine systems. Open Med (Wars) 2021;16:640-50. [PMID: 33954257 DOI: 10.1515/med-2021-0264] [Reference Citation Analysis]
10 Awany D, Chimusa ER. Heritability jointly explained by host genotype and microbiome: will improve traits prediction? Brief Bioinform 2021;22:bbaa175. [PMID: 32810866 DOI: 10.1093/bib/bbaa175] [Reference Citation Analysis]